Insights Into the Pathogenicity of Rare Missense GCK Variants From the Identification and Functional Characterization of Compound Heterozygous and Double Mutations Inherited in Cis

被引:13
作者
Beer, Nicola L. [1 ,2 ]
Osbak, Kara K. [1 ]
van de Bunt, Martun [1 ]
Tribble, Nicholas D. [1 ]
Steele, Anna M. [3 ]
Wensley, Kirsty J. [3 ]
Edghill, Emma L. [3 ]
Colcough, Kevin [4 ]
Barrett, Amy [1 ]
Valentinova, Lucia [1 ,5 ]
Rundle, Jana K. [1 ]
Raimondo, Anne [1 ]
Grimsby, Joseph [6 ]
Ellard, Sian [3 ,4 ]
Gloyn, Anna L. [1 ,7 ]
机构
[1] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England
[2] Broad Inst & Harvard, Program Med & Populat Genet, Cambridge, MA USA
[3] Univ Exeter, Peninsula Med Sch, Inst Biomed & Clin Sci, Exeter, Devon, England
[4] Royal Devon & Exeter NHS Trust, Dept Mol Genet, Exeter, Devon, England
[5] Slovak Acad Sci, Inst Expt Endocrinol, Bratislava, Slovakia
[6] Hoffmann La Roche Inc, Dept Metab Dis, Nutley, NJ 07110 USA
[7] Churchill Hosp, Oxford Natl Inst Hlth Res, Oxford OX3 7LJ, England
基金
英国惠康基金; 美国国家卫生研究院; 英国医学研究理事会;
关键词
GLUCOKINASE ACTIVITY; YOUNG TYPE-2; HYPOGLYCEMIA; MUTANTS; GLUCOSE;
D O I
10.2337/dc11-2420
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE-To demonstrate the importance of using a combined genetic and functional approach to correctly interpret a genetic test for monogenic diabetes. RESEARCH DESIGN AND METHODS-We identified three probands with a phenotype consistent with maturity-onset diabetes of the young (MODY) subtype GCK-MODY, in whom two potential pathogenic mutations were identified: [R43H/G68D], [E248 K/1225M], or [G261R/D217N]. Allele-specific PCR and cosegregation were used to determine phase. Single and double mutations were kinetically characterized. RESULTS-The mutations occurred in cis (double mutants) in two probands and in trans in one proband. Functional studies of all double mutants revealed inactivating kinetics. The previously reported GCK-MODY mutations R43H and G68D were inherited from an affected father and unaffected mother, respectively. Both our functional and genetic studies support R43H as the cause of GCK-MODY and G68D as a neutral rare variant. CONCLUSIONS-These data highlight the need for family/functional studies, even for previously reported pathogenic mutations.
引用
收藏
页码:1482 / 1484
页数:3
相关论文
共 13 条
[1]   A map of human genome variation from population-scale sequencing [J].
Altshuler, David ;
Durbin, Richard M. ;
Abecasis, Goncalo R. ;
Bentley, David R. ;
Chakravarti, Aravinda ;
Clark, Andrew G. ;
Collins, Francis S. ;
De la Vega, Francisco M. ;
Donnelly, Peter ;
Egholm, Michael ;
Flicek, Paul ;
Gabriel, Stacey B. ;
Gibbs, Richard A. ;
Knoppers, Bartha M. ;
Lander, Eric S. ;
Lehrach, Hans ;
Mardis, Elaine R. ;
McVean, Gil A. ;
Nickerson, DebbieA. ;
Peltonen, Leena ;
Schafer, Alan J. ;
Sherry, Stephen T. ;
Wang, Jun ;
Wilson, Richard K. ;
Gibbs, Richard A. ;
Deiros, David ;
Metzker, Mike ;
Muzny, Donna ;
Reid, Jeff ;
Wheeler, David ;
Wang, Jun ;
Li, Jingxiang ;
Jian, Min ;
Li, Guoqing ;
Li, Ruiqiang ;
Liang, Huiqing ;
Tian, Geng ;
Wang, Bo ;
Wang, Jian ;
Wang, Wei ;
Yang, Huanming ;
Zhang, Xiuqing ;
Zheng, Huisong ;
Lander, Eric S. ;
Altshuler, David L. ;
Ambrogio, Lauren ;
Bloom, Toby ;
Cibulskis, Kristian ;
Fennell, Tim J. ;
Gabriel, Stacey B. .
NATURE, 2010, 467 (7319) :1061-1073
[2]   Discovery of a Novel Site Regulating Glucokinase Activity following Characterization of a New Mutation Causing Hyperinsulinemic Hypoglycemia in Humans [J].
Beer, Nicola L. ;
van de Bunt, Martijn ;
Colclough, Kevin ;
Lukacs, Christine ;
Arundel, Paul ;
Chik, Constance L. ;
Grimsby, Joseph ;
Ellard, Sian ;
Gloyn, Anna L. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (21) :19118-19126
[3]   The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver [J].
Beer, Nicola L. ;
Tribble, Nicholas D. ;
McCulloch, Laura J. ;
Roos, Charlotta ;
Johnson, Paul R. V. ;
Orho-Melander, Marju ;
Gloyn, Anna L. .
HUMAN MOLECULAR GENETICS, 2009, 18 (21) :4081-4088
[4]   Cell-biological assessment of human glucokinase mutants causing maturity-onset diabetes of the young type 2 (MODY-2) or glucokinase-linked hyperinsulinaemia (GK-HI) [J].
Burke, CV ;
Buettger, CW ;
Davis, EA ;
McClane, SJ ;
Matschinsky, FM ;
Raper, SE .
BIOCHEMICAL JOURNAL, 1999, 342 :345-352
[5]   Clinical Heterogeneity in Monogenic Diabetes Caused by Mutations in the Glucokinase Gene (GCK-MODY) [J].
Cuesta-Munoz, Antonio L. ;
Tuomi, Tiinamaija ;
Cobo-Vuilleumier, Nadia ;
Koskela, Hanna ;
Odili, Stella ;
Stride, Amanda ;
Buettger, Carol ;
Otonkoski, Timo ;
Froguel, Philippe ;
Grimsby, Joseph ;
Garcia-Gimeno, Maria ;
Matschinsky, Franz M. .
DIABETES CARE, 2010, 33 (02) :290-292
[6]   Mutants of glucokinase cause hypoglycaemia- and hyperglycaemia syndromes and their analysis illuminates fundamental quantitative concepts of glucose homeostasis [J].
Davis, EA ;
Cuesta-Muñoz, A ;
Raoul, M ;
Buettger, C ;
Sweet, I ;
Moates, M ;
Magnuson, MA ;
Matschinsky, FM .
DIABETOLOGIA, 1999, 42 (10) :1175-1186
[7]   Allosteric activators of glucokinase: Potential role in diabetes therapy [J].
Grimsby, J ;
Sarabu, R ;
Corbett, WL ;
Haynes, NE ;
Bizzarro, FT ;
Coffey, JW ;
Guertin, KR ;
Hilliard, DW ;
Kester, RF ;
Mahaney, PE ;
Marcus, L ;
Qi, LD ;
Spence, CL ;
Tengi, J ;
Magnuson, MA ;
Chu, CA ;
Dvorozniak, MT ;
Matschinsky, FM ;
Grippo, JF .
SCIENCE, 2003, 301 (5631) :370-373
[8]   Structural instability of mutant beta-cell glucokinase: Implications for the molecular pathogenesis of maturity-onset diabetes of the young (type-2) [J].
Kesavan, P ;
Wang, LQ ;
Davis, E ;
Cuesta, A ;
Sweet, I ;
Niswender, K ;
Magnuson, MA ;
Matschinsky, FM .
BIOCHEMICAL JOURNAL, 1997, 322 :57-63
[9]  
Loomba-Albrecht Lindsey A, 2010, Diabetes Res Clin Pract, V87, pe23, DOI 10.1016/j.diabres.2009.11.013
[10]   An infant with combination gene mutations for Monogenic Diabetes of Youth (MODY) 2 and 4, presenting with Diabetes Mellitus Requiring Insulin (DMRI) at 8 months of age [J].
Odem, Jamie ;
Munzinger, Ethan ;
Violand, Sarah ;
Van Morlan, Amie ;
Rife, Danita ;
Bachrach, Bert .
PEDIATRIC DIABETES, 2009, 10 (08) :550-553